Stockscreener 앱 받기
1.775
3.76%
-0.075
전일 마감가:
$1.85
열려 있는:
$1.89
하루 거래량:
1.15M
Relative Volume:
0.42
시가총액:
$187.43M
수익:
-
순이익/손실:
$-37.34M
주가수익비율:
-1.3051
EPS:
-1.36
순현금흐름:
$-36.91M
1주 성능:
+14.86%
1개월 성능:
-3.76%
6개월 성능:
+40.19%
1년 성능:
+35.91%
1일 변동 폭
$1.78
$1.8971
1주일 범위
$1.53
$1.8971
52주 변동 폭
$0.772
$2.2691
Sellas Life Sciences Group Inc Stock (SLS) Company Profile
명칭
Sellas Life Sciences Group Inc
전화
(646) 200-5278
주소
7 TIMES SQUARE, NEW YORK, NY
SLS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SLS
Sellas Life Sciences Group Inc
|
1.78 | 182.16M | 0 | -37.34M | -36.91M | -1.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
398.15 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
600.78 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.08 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
664.22 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.18 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Sellas Life Sciences Group Inc Stock (SLS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-07-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-11-01 | 개시 | Oppenheimer | Outperform |
| 2018-04-02 | 개시 | H.C. Wainwright | Buy |
| 2018-03-19 | 업그레이드 | Maxim Group | Hold → Buy |
Sellas Life Sciences Group Inc 주식(SLS)의 최신 뉴스
SELLAS Life Sciences’ Triumphant Advances - StocksToTrade
Sellas Life Sciences: SLS009’s Phase 2 Sets Up A Promising 2026 (NASDAQ:SLS) - Seeking Alpha
SELLAS Life Sciences Rises On Cancer Trial Progress And New Listings - Finimize
What’s the fair value of SELLAS Life Sciences Group Inc. stockEarnings Recap Summary & Low Drawdown Momentum Ideas - mustnews.co.kr
Published on: 2025-08-15 06:21:10 - beatles.ru
Chart Patterns Forming a Bullish Setup in SELLAS Life Sciences Group Inc.2025 Technical Patterns & Real-Time Volume Trigger Notifications - beatles.ru
Optimistic Buy Rating for SELLAS Life Sciences Group Driven by Promising Trial Results and Financial Stability - TipRanks
Sellas Life Sciences Reports Q2 2025 Financial Results - TipRanks
Sellas Life Sciences Group Inc reports results for the quarter ended June 30Earnings Summary - TradingView
SELLAS Life Sciences Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Sellas Life Sciences' GPS Trial Continues with Positive IDMC Recommendation - AInvest
SELLAS Life Sciences Receives Positive IDMC Recommendation to Continue Phase 3 REGAL Trial of GPS in AML. - AInvest
Sellas Life Sciences Group Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView
SELLAS Life Sciences Announces Independent Data Monitoring Committee Periodic Review and Positive Recommendation to Continue Pivotal Phase 3 Regal Trial of GPS in AML Without Modification - MarketScreener
SELLAS Life Sciences Gets Positive IDMC Nod To Continue Phase 3 Trial Of AML Treatment - Nasdaq
SELLAS Life Sciences Announces Independent Data Monitoring Committee Periodic Review and Positive Recommendation to Continue Pivotal Phase 3 REGAL Trial of GPS in AML Without Modification - The Manila Times
IDMC recommends continuation of Phase 3 AML trial for galinpepimut-S - Investing.com India
SELLAS Life Sciences Announces Independent Data Monitoring - GlobeNewswire
SELLAS Phase 3 Cancer Drug GPS Clears Critical Safety Review, Final Data Expected This Year - Stock Titan
SELLAS Life Sciences Group Inc. Consolidation Zone May Signal AccumulationMulti-Bagger Potential Stock Forecast Tools Released - metal.it
What institutional investors are buying SELLAS Life Sciences Group Inc. stockGet alerts on top growth stocks daily - Jammu Links News
What analysts say about SELLAS Life Sciences Group Inc. stockDiscover investment plans that deliver results - Jammu Links News
What is the risk reward ratio of investing in SELLAS Life Sciences Group Inc. stockBuild a portfolio for long-term financial success - Jammu Links News
Does SELLAS Life Sciences Group Inc. stock perform well during market downturnsExceptional profit velocity - Jammu Links News
How does SELLAS Life Sciences Group Inc. compare to its industry peersBreakout stock performance - Jammu Links News
What are the latest earnings results for SELLAS Life Sciences Group Inc.Achieve fast wealth growth with smart picks - Jammu Links News
What are analysts’ price targets for SELLAS Life Sciences Group Inc. in the next 12 monthsRapid profit acceleration - Jammu Links News
What makes SELLAS Life Sciences Group Inc. stock price move sharplyGet professional advice for portfolio optimization - Jammu Links News
What are SELLAS Life Sciences Group Inc. company’s key revenue driversInvest smarter with daily stock recommendations - Jammu Links News
SELLAS Life Sciences Group (SLS) Upgraded to Buy: What Does It Mean for the Stock? (Revised) - MSN
What is the dividend policy of SELLAS Life Sciences Group Inc. stockRetirement Planning Watchlist For Every Investor - Jammu Links News
SELLAS Life Sciences : Corporate PresentationAugust 2025 - MarketScreener
What catalysts could drive SELLAS Life Sciences Group Inc. stock higher in 2025Wealth Building Trend Scanner For Smart Trading - Jammu Links News
Published on: 2025-07-31 14:02:06 - beatles.ru
Sector Leaders Rotate Capital Into SELLAS Life Sciences Group Inc.Stock Screener With Smart Filters Highlights Top Picks - beatles.ru
Published on: 2025-07-29 08:30:26 - metal.it
What risks could impact SELLAS Life Sciences Group Inc. stock performanceIntraday Trend Analysis for Fast Gains Released - beatles.ru
Should I hold or sell SELLAS Life Sciences Group Inc. stock in 2025Market Forecast Updates That Work - Jammu Links News
How strong is SELLAS Life Sciences Group Inc. company’s balance sheetFree Technical Analysis Support - jammulinksnews.com
How Resilient Is SELLAS Life Sciences Group Inc. Stock During Economic DownturnsTop Performer Shortlist - metal.it
SELLAS Life Sciences Group Inc. Stock Analysis and ForecastTriple-digit profit margins - PrintWeekIndia
What institutions are buying SELLAS Life Sciences Group Inc. stock nowStrong return on assets - Jammu Links News
What drives SELLAS Life Sciences Group Inc. stock priceUnprecedented growth rates - PrintWeekIndia
Is SELLAS Life Sciences Group Inc. a good long term investmentExceptional profit potential - PrintWeekIndia
Sellas Life Sciences Group Inc (SLS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Sellas Life Sciences Group Inc 주식 (SLS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Wasman Jane | Director |
May 30 '25 |
Buy |
1.69 |
20,000 |
33,800 |
30,400 |
| Kalin Katherine Bach | Director |
May 22 '25 |
Buy |
1.80 |
20,000 |
36,000 |
41,000 |
0.94%
0.64%
자본화:
|
볼륨(24시간):